Healthcare Industry Digital

How Will Connected Devices Impact the Future of Healthcare?

May 15, 2019 | AplusA

Ninety-nine percent of young, French health care practitioners have a smartphone and 94% of them use a smartphone for professional purposes including internet medical research, professional social...

Read More

Patients Digital

Doctors and New Technology: The Slow Adopters

May 14, 2019 | AplusA

The development of digital technology in healthcare shows no signs of slowing down. Certain healthcare professionals are concerned by the rapid development of new digital tools, while others...

Read More

Patients Digital

What are The Effects of Technology According to Doctors in France and the UK?

May 10, 2019 | AplusA

New digital technologies impact our personal and professional lives daily. Medical professionals and patients alike have experienced the significant increase in the capabilities and volume of...

Read More

Healthcare Industry hemato-oncology

Who Are The Key Hemato-Oncology Market Stakeholders?

April 9, 2019 | AplusA

As a marketing professional in the healthcare industry, you need to accurately identify the criteria that define your specific target population in order to size your market and build your...

Read More

Healthcare Industry Digital hemato-oncology

Who are the Digital Opinion Leaders in Hemato-Oncology?

April 4, 2019 | AplusA

KOLs (Key Opinion Leaders) have long since played an important and influential role in the healthcare industry. In recent years we have seen the emergence and rapid rise in the influence of DOLs...

Read More

Healthcare Industry Market Research Industry hemato-oncology

5 Benefits of Syndicated Research in the Hematology Oncology Market

April 1, 2019 | AplusA

In the rapidly evolving onco -hematology market, syndicated research provides critical insights based on real-world data in order to support strategic decision making within pharmaceutical and ...

Read More

hemato-oncology

DLBCL Treatment: A Quick Overview

March 11, 2019 | AplusA

DLBCL is the most common form of non-Hodgkin’s lymphoma (NHL), constituting 30% to 58% of lymphoma cases.

Read More

hemato-oncology

Why is the Hemato-Oncology Market Complex for Market Researchers?

February 27, 2019 | AplusA

The hematology oncology market is one of the most rapidly developing, with over sixty oncology drugs having been approved by the FDA in the last five years. Advances in targeted therapies,...

Read More

hemato-oncology

Chronic Lymphocytic Leukemia: Current and Future CLL Treatments

January 24, 2019 | AplusA

Chronic Lymphocytic Leukemia is the most common form of leukemia in Western countries. Although currently incurable, there have been significant advances in research efforts of CLL treatments in...

Read More

Therapeutic Areas hemato-oncology

Blood Cancer Treatments: Current and Future

December 11, 2018 | AplusA

Despite being considered as rare diseases, blood cancers account for 8% of all cancers and mainly affect children, young adults and the elderly. Each of the three main families of hematological...

Read More